Stocks · Health care · Pharmaceutical Preparations

CorMedix Inc.

CRMD Clue Score73
United States Fiscal year ends December CIK 0001410098 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Janet Dillione
21 Jan 2026
Director
Sold on a plan
10,000
$6.88
$68.80K
Joseph Todisco
16 Jan 2026
Chief Executive Officer
Exercised, kept
29,585
$3.38
$100.00K
Steven W Lefkowitz
12 Jan 2026
Director
Exercised, kept
15,000
$5.63
$84.45K
Alan W Dunton
30 Dec 2025
Director
Sold after exercise
20,000
$13.00
$260.00K
Joseph Todisco
18 Dec 2025
Chief Executive Officer
Sold after exercise
30,000
$12.00
$360.00K
Steven W Lefkowitz
9 Dec 2025
Director
Sell
40,000
$11.88
$475.20K
Janet Dillione
9 Dec 2025
Director
Sold after exercise
34,000
$12.00
$408.00K
Janet Dillione
2 Dec 2025
Director
Sold after exercise
46,657
$10.00
$466.57K
Janet Dillione
24 Nov 2025
Director
Sold after exercise
26,343
$9.93
$261.59K
Janet Dillione
14 Nov 2025
Director
Sell
30,000
$11.42
$342.60K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 5
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,329,768
History held since 1 Apr 2010